-
1.
公开(公告)号:US4464468A
公开(公告)日:1984-08-07
申请号:US369253
申请日:1982-04-16
申请人: Stratis Avrameas , Georges Broun , Eric Selegny , Daniel Thomas
发明人: Stratis Avrameas , Georges Broun , Eric Selegny , Daniel Thomas
CPC分类号: A61K39/44 , A61K35/74 , A61K35/742 , A61K38/363 , A61K38/38 , A61K38/443 , A61K38/47 , A61K38/4826 , A61K38/51 , C12N11/02 , Y10S530/816
摘要: A solution of an active protein substance and an inactive protein substance is reacted with a cross-linking agent, optionally in the presence of an inert carrier, under cross-linking conditions to produce articles comprising both active and inactive protein substances. The active protein substance comprises up to about 20 percent, e.g. from 1 to 20 percent by weight, based on the final weight of the total protein substance, whereas the cross-linking agent comprises from 0.5 to 8 percent by weight, based on the weight of the total treated mixture. The obtained articles are in the form of a solution or a suspension in aqueous medium, in the form of a film, in the form of a membrane, in the form of a fabric, in the form of a porous material, or in the form of a mass, such as granules, pills or tablets.
摘要翻译: 将活性蛋白质物质和无活性蛋白质物质的溶液与交联剂(任选在惰性载体存在下)在交联条件下反应,以产生包含活性和非活性蛋白质物质的制品。 活性蛋白物质包含至多约20%,例如 基于总蛋白质物质的最终重量为1至20重量%,而交联剂占总处理混合物的重量的0.5至8重量%。 所获得的制品是以水溶液或悬浮液形式的水溶液或悬浮液形式的水溶液或悬浮液,形式为多孔材料形式的膜形式的薄膜形式,或形式为 的颗粒,丸剂或片剂。
-
公开(公告)号:US4004979A
公开(公告)日:1977-01-25
申请号:US541257
申请日:1975-01-15
申请人: Stratis Avrameas , Georges Broun , Eric Selegny , Daniel Thomas
发明人: Stratis Avrameas , Georges Broun , Eric Selegny , Daniel Thomas
CPC分类号: C12N11/02 , A61K35/74 , A61K38/363 , A61K38/38 , A61K38/443 , A61K38/4826 , A61K38/51 , A61K39/44 , C12N11/14 , Y10S436/823 , Y10S530/81 , Y10S530/812
摘要: Articles containing active proteins, such as enzymes, crosslinked to an inactive protein are prepared by dispersing and reacting in a solvent an active protein and an inactive protein simultaneously with a crosslinking agent to crosslink the active and inactive proteins together. The degree of crosslinking can be controlled by introducing tris (hydroxymethyl) aminomethane in an amount sufficient to stop chain growth. Optionally, an inert carrier may be present during crosslinking. The resultant crosslinked active and inactive proteins can be in various forms such as solutions, suspensions, gels, films, membranes, granules, pills or tablets.
摘要翻译: 通过将活性蛋白质和无活性蛋白质与交联剂同时分散和反应以将活性和非活性蛋白质交联到一起,制备含有与无活性蛋白质交联的活性蛋白质如酶的制品。 可以通过引入足以阻止链生长的量的三(羟甲基)氨基甲烷来控制交联度。 任选地,在交联过程中可能存在惰性载体。 所得到的交联的活性和非活性蛋白质可以是各种形式,例如溶液,悬浮液,凝胶,膜,膜,颗粒,丸剂或片剂。
-
3.
公开(公告)号:US4970156A
公开(公告)日:1990-11-13
申请号:US775956
申请日:1985-09-13
申请人: Statis Avrameas , Georges Broun , Eric Selegny , Daniel Thomas
发明人: Statis Avrameas , Georges Broun , Eric Selegny , Daniel Thomas
IPC分类号: A61L27/00 , A61K38/00 , A61K39/00 , A61K39/44 , C12N5/00 , C12N11/00 , C12N11/02 , C12N11/06 , C12N11/08 , C12N11/12 , C12N11/14 , D06M15/11 , D06M16/00
CPC分类号: A61K38/443 , A61K38/38 , A61K38/47 , A61K38/4826 , A61K38/51 , A61K39/44 , C12N11/00 , C12N11/02 , C12N11/14 , C12N5/0068 , D06M15/11 , D06M16/00 , Y10S530/81 , Y10S530/811 , Y10S530/812 , Y10S530/814 , Y10S530/815
摘要: A solution of an active protein substance and an inactive protein substance is reacted with a cross-linking agent, optionally in the presence of an inert carrier, under cross-linking conditions to produce articles comprising both active and inactive protein substances. The active protein substance comprises up to about 20 percent, e.g. from 1 to 20 percent by weight, based on the final weight of the total protein substance, whereas the cross-linking agent comprises from 0.5 to 8 percent by weight, based on the weight of the total treated mixture. The obtained articles are in the form of a solution or a suspension in aqueous medium, in the form of a film, in the form of a membrane, in the form of a fabric, in the form of a porous material, or in the form of a mass, such as granules, pills or tablets.
摘要翻译: 将活性蛋白质物质和无活性蛋白质物质的溶液与交联剂(任选在惰性载体存在下)在交联条件下反应,以产生包含活性和非活性蛋白质物质的制品。 活性蛋白物质包含至多约20%,例如 基于总蛋白质物质的最终重量为1至20重量%,而交联剂占总处理混合物的重量的0.5至8重量%。 所获得的制品是以水溶液或悬浮液形式的水溶液或悬浮液形式的水溶液或悬浮液,形式为多孔材料形式的膜形式的薄膜形式,或形式为 的颗粒,丸剂或片剂。
-
-